Digital Diabetes Management Market To Generate Revenue worth $43.4 Billion in 2030

The global digital diabetes management market is projected to generate USD 43.4 billion revenue by 2030, advancing at a CAGR of 13.7% during 2024–2030. Digital diabetes care solutions have grown in importance due to the rising prevalence of diabetes. The market is also expanding due to the growing geriatric population, government initiatives for enhancing patient outcomes, and technical developments in the digital diabetes monitoring space.

Moreover, in the coming years, the adoption of continuous blood glucose monitoring devices will rise as they enable patients to conveniently and effectively track their levels of blood glucose. The increase in the R&D expenditure by governments and the aggressive growth tactics of the top competitors, such as product launches, are fostering the market expansion.

The changes in the lifestyle, which are characterized by the high intake of tobacco and alcohol, are the key risk factors for diabetes. Another reason the incidence of this common endocrine disorder is increasing is obesity. As people become aware of these risk factors and the long way diabetes management has come, the demand for mobile apps that help people manage their weight and diet will increase.

Rising Prevalence of Diabetes Boosts Market Growth

Currently, approximately 537 million people have diabetes worldwide, and it is expected that the number will reach 783 million by 2045. Moreover, according to the WHO, by 2030, diabetes is expected to become the seventh-leading cause of death. The main risk factors for diabetes are stress, sedentary habits, poor diets, and obesity. Age-related physical changes are also a key risk factor for this condition; therefore, those over 65 years old have the highest estimated prevalence.

Homecare Settings Dominate Market

In 2030, the homecare category will hold the largest digital diabetes management market share, of 45%, due to the emergence of various advanced technologies that can be used to support and improve diabetes care by informing people of lower- or higher-than-normal blood glucose levels.

By using technologies such as mHealth apps, wearables, and blood glucose tracking apps, early intervention and effective responsive care become possible. This way, the home connects directly to the medical community, thus offering readily available support and easier communication. These approaches allow people to stay one step ahead of their condition, which, ultimately, enhances their quality of life and offers them mental peace.

APAC is expected to emerge as the fastest-growing market, driven by product launches, a large diabetic population, and increasing number of government initiatives for raising awareness of digital diabetes management tools. Additionally, the favorable reimbursement policies, growing count of smartphone users, increasing disposable income, and rising health awareness are predicted to encourage the growth of this regional market.

Furthermore, developing countries, including India and China, are witnessing a rapid rise in the adoption of digital tools for diabetes management because of the large patient population. In addition, the government in these countries is augmenting their R&D expenditure to enable patients to receive better treatments empowered by new technologies. Further, after China, India is home to the largest diabetic population in the world, thus encouraging the key market players to focus here.

Some of the major market players are Abbott Laboratories, Medtronic plc, Sanofi S.A., DexCom Inc., DarioHealth Corp., and F. Hoffmann-La Roche Ltd.